• Home
  • Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.

Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.

Author List
Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP
Publication
The Prostate
Publication ID (Profile URL)
https://researcherprofiles.org/profile/136666810
Publication Year
2020
PubMed ID
32946625
Publication Title
Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428.